Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase EARLY_PHASE1 1

Status

Completed 3Active not recruiting 2Unknown 1

Sponsor Class

OTHER 6

Study Type

Interventional 6Observational 2

Sponsor

Cancer Type

CNS 2Tumor-Agnostic 1Thoracic 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Neoplasms 6Fatigue 6Breast Neoplasms 5Anxiety Disorders 3Psychological Well-Being 2Pain 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Depression 2Caregiver Burden 2Uterine Neoplasms 1Tuberous Sclerosis 1Substance-Related Disorders 1Smoking Cessation 1Sleep Wake Disorders 1Sleep Initiation and Maintenance Disorders 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain, Postoperative 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neoplasm Regression, Spontaneous 1Multiple Myeloma 1Malignant Hepatobiliary Neoplasm 1Lymphoma 1Leukemia 1Hematopoietic Cell Transplantation Recipient 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Acceptance and Commitment Therapy × Clear all
NCT01098955 2026-05-22

Smoking Cessation Treatment for Head & Neck Cancer Patients

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
51 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms, Smoking Cessation

NCT05643027 2026-05-14

ACTION

Dana-Farber Cancer Institute

Phase NA Completed
40 enrolled

Neoplasms, Substance-Related Disorders

NCT05126823 2026-05-05

Efficacy of a Combined ACT+ App Intervention to Improve Psychological Flexibility and Associated Symptoms in Cancer Patients

Universidad de Córdoba

Phase NA Active not recruiting
120 enrolled
Tumor-Agnostic

Neoplasms

NCT03661840 2025-03-13

Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors

University of Colorado, Denver

Phase NA Completed
50 enrolled 12 charts

Agnosia, Neoplasms, Chronic Pain

NCT04722237 2023-08-31

ACT NOW

Nottingham University Hospitals NHS Trust

Phase NA Unknown
72 enrolled
CNS

Brain Neoplasms, Neoplasms

NCT01929720 2017-04-05

FOCUS

Ohio State University Comprehensive Cancer Center

Phase NA Completed
33 enrolled
CNSGastrointestinalGynecologicLymphoidOther hematologic neoplasmPlasma cellThoracic

Anxiety Disorders, Depression, Esophageal Neoplasms, Fatigue, Glioblastoma, Sleep Initiation and Maintenance Disorders, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Pain, Pancreatic Neoplasms, Sleep Wake Disorders, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡